in the jugular chain or supraclavicular fossa has a node excised and it is found to contain papillary carcinoma. The disease typically affects young adults and spreads by lymphatics. Once it has escaped from the thyroid gland into the adjoining lymph nodes it can reasonably be expected to have spread by intraglandular lymphatics to the opposite lobe of the gland. For this reason I perform total thyroidectomy when such a node is found. The term total thyroidectomy is sometimes used loosely to include extracapsular excision of one lobe and intracapsular removal of the other. It should mean extracapsular excision of both lobes. A tracer dose of radioiodine having been given on the previous day a probe counter in the wound demonstrates any remaining functioning thyroid tissue. If any operative difficulty is encountered a rim of normal thyroid tissue can be left posteriorly to protect nerves and parathyroids and can be subsequently destroyed with radioactive iodine. The important thing is to excise all the carcinoma.
When lymph node deposits in the neck are found to be cystic the prognosis is usually excellent since it indicates a degree of differentiation and extremely slow growth. There are many records in the literature of patients who have had positive nodes of this kind removed from the neck with little subsequent spread of the disease for as long as 25 years. The removal of involved lymph nodes is carried out individually, and not by block dissection, since they appear to be enveloped in little fascial pockets which makes it easy to shell them out. The thymus may be excised with them in clearing the area inferiorly and it may be necessary to excise part of a jugular vein if its walls are involved. When the trachea is involved by direct extension part can be excised and the opening used for tracheostomy. As a temporary closure a piece of teflon aortic graft may be helpful.
Carcinoma Presenting as Distant Metastases
Follicular carcinoma of the thyroid, usually seen in the middle decades of life, presents at least as often with metastases in bone or lung as with the primary lesion in the thyroid. The primary is a solitary, springy nodule, often mobile. If there is clear evidence that a follicular carcinoma has metastasized to bone or lung I prefer to perform a total thyroidectomy. This removes the primary, preventing further lesions being spilled into the blood stream, and also removes any normal thyroid tissue thus making the task of treating the secondaries with radioactive iodine easier. Alternatively the carcinoma and surrounding thyroid tissue is excised and the remainder of the gland ablated with radioactive iodine. This, however, takes many weeks during which the metastases may grow appreciably. When secondary deposits do not take up radioiodine there is rarely any indication for their surgical removal, thoughIhave excised a rib containing an apparently solitary deposit.
Medullary Carcinoma
This, the rarest of the differentiated thyroid carcinomas, can occur at any age. It arises from' cells of the neural crest and is thus equally common in males and females and does not take up iodine. It may present as a hard mass in the thyroid gland together with any of the signs and symptoms due to the polypeptide hormones which these endocrine tumours, which Pearse calls apudomas, may secrete. Growth may be slow and the deposits are often calcified and spread into the upper mediastinum. Treatment, if it can be accomplished, is complete removal by the surgeon. If this is impossible, radiotherapy and chemotherapy will then be necessary.
Thyroid Carcinoma ofChildhood
This rare disease carries a much better prognosis than might be expected. It usually shows a mixture of papillary and follicular elements and may produce multiple metastases in the lungs which can be mistaken for sarcoidosis or tuberculosis. The diagnosis is usually made on examination of tissue excised from the thyroid or cervical lymph aodes. Dunhill reported in 1937 that such metastases are often hormone dependent and that by giving thyroid hormone by mouth, metastases may shrink or be arrested. I have records of 3 of his patients, two of whom grew up, married and had children.
This observation of Dunhill's underlines the rationale for giving thyroid hormone to all patients after excision of thyroid cancer, for the rest of their lives. 
Tumours and its Results
A series of472 thyroid tumours treated in Glasgow between 1930 and 1971 is described. The patients are divided into seven groups: 'no histology' 119, anaplastic carcinoma 138, predominantly papillary carcinoma 112, predominantly follicular Section ofOncology carcinoma 43, medullary carcinoma 7, thyroid lymphoma 41, 'other' tumours 12.
'No histology' group: Most of those without histology belong to the early years, and many were elderly women with rapidly growing tumours. They were almost certainly predominantly anaplastic carcinomas, though some were probably lymphomas.
Anaplastic carcinoma: These carry a very poor prognosis, 74 % being dead within one year. However, 11 % were alive and well at five years and 8 % at ten years. All but 3 of these long-term survivors have been histologically reviewed and confirmed.
Differentiated tumours: Since these lesions are almost always mixed we have described them as predominantly papillary or predominantly follicular. Survival figures for the two groups are similar, 52% of the papillary group being well at ten years and 40% of the follicular group; 35% of all differentiated tumours were inoperable on referral. In both groups 56% died with active tumour in the neck. In the follicular group 22% died with distant metastases, compared with only 10% in the papillary group.
Of the papillary group 20% took up radioiodine; one is well at fifteen years, one at seven years, 3 at six years and 10 others for shorter periods. One six-year survivor presented with incipient paraplegia due to spinal metastases but remains well and at work.
In the follicular group 35% took up radioiodine. One is well at ten years, 2 at six years and 6 others for shorter periods. The ten-year survivor presented with a histologically proven pathological fracture of the femur and remains well and mobile having been treated by radioiodine and thyroxine only.
Medullary carcinoma: There are only 7 of these tumours in our series. One is well sixteen years after incomplete surgery followed by radiotherapy.
Thyroid lymphoma: Like lymphoma elsewhere, thyroid lymphoma is highly radiosensitive as shown by a local recurrence rate of only 8 % compared to 80 % local recurrence in anaplastic carcinoma and 56 % in differentiated tumours. Of the thyroid lymphomas 50 % were well at five years and 45 % at ten years. No patient who was well 18 months after treatment subsequently had a recurrence, though some died of other causes.
'Other' tumours: Our small group of histological rarities comprised 6 fibrosarcomas, 5 squamous carcinomas and one osteogenic sarcoma. All did uniformly badly.
Treatment
Our present treatment policies are as follows:
Anaplastic carcinoma: If operable total thyroidectomy is carried out and is routinely followed by supervoltage radiation to 4500 rad tumour minimum dose in four weeks. The upper mediastinum is included in the treated volume. Inoperable tumours are identically irradiated.
Differentiated tumours: Predominantly papillary and predominantly follicular tumours are treated identically, total thyroidectomy in operable lesions being followed by radioiodine scans and uptakes. Any localized uptake is an indication for radioiodine therapy, a dose of 200 mCi 1311 being given. This may be repeated up to four times at not less than three-monthly intervals, the indication for each dose being the persistence of localized uptake on tracer scans.
In patients with inoperable lesions external irradiation is given but isotope uptake should be assessed beforehand and this cannot be done without first destroying all normal thyroid tissue. The dose of external irradiation is 5000 rad tumour in four weeks unless radioiodine is also given when the dose is reduced to 4500 rad tumour minimum in four weeks. Metastatic differentiated tumours are treated by radioiodine if uptake occurs and external irradiation may also be used to relieve symptoms. All patients with differentiated tumours are maintained on full doses of thyroid hormone.
Medullary carcinoma: Total thyroidectomy is carried out in operable lesions and if removal is complete no radiotherapy need be given. If tumour is left behind, and in inoperable cases, 5000 rad tumour minimum dose is given in four weeks.
Thyroid lymphoma: Total thyroidectomy is not essential but a generous biopsy is required for accurate histological diagnosis. The thyroid and the whole mediastinum are irradiated to 3500 rad tumour minimum dose in four weeks.
There is no place for radioiodine therapy or suppressive doses of thyroid hormone in anaplastic carcinoma, medullary carcinoma or thyroid lymphoma.
We believe thyroid tumour management should be tailored to the individual patient and therefore close cooperation between surgeon, radiotherapist, pathologist and endocrinologist is essential.
